EQ Labs and Timbaland Announces Major North American Roll
Out
Las Vegas, NV, November 18, 2015 EQ Labs, Inc. (EQ. or the
Company) (OTC.BB: EQLB), is pleased to update you on the expanding
role of Timothy Mosley aka Timbaland in our market launch. Mr.
Mosley will be the principal spokesman for our lead product Last
Shot. This will include his support through social media, national
commercials, advertising and endorsement of our product.
We are excited to have Timbaland Mosley as our new Equity
Partner for, "Last Shot", the 3 in 1 can beverage. Cranberry flavor
helps Energize, Hydrate and Detox its consumers states Mo Owens,
CEO of EQ. This product is being made available to the retail
customers through bars, night clubs, hotel resorts and golf courses
throughout the Las Vegas area throughout the end of this year. Mr.
Owens further stated There are roughly 150,000 rooms with mini bars
in Las Vegas. With 10% of the mini bars in the Las Vegas rooms
alone and a major distribution effort to assist us with the Las
Vegas roll out, revenue from those venues alone could potential
exceed $6 million. Owens also stated the ground work put into this
marketing campaign over the past years is now coming to
fruition.
Timothy Moseley proudly states Mo and I have major plans for EQ
in the month to come, weve been working diligently on our new
partnership to bring my resources and venue for the introduction of
Last Shot cranberry flavor Cold Beverage to North American market.
I am excited to be hands on project like this.
About EQ Lab, Inc.:
EQ Labs, Inc is a leader in the marketing and development of
measured product release devices for the retail market. Its
products will be sold through major retail stores, casinos,
beverage distribution outlets and chains throughout the US. Leading
products include Last Shot 3 in 1 Hangover Protection Cranberry
Cold Beverage, 5 Cal/2 Carbs dietary supplement energize *hydrate*
detox.
Safe Harbor:
This news release contains forward-looking statements as that
term is defined in Section 27A of the United States Securities Act
of 1933, as amended and Section 21E of the Securities Exchange Act
of 1934, as amended. Statements in this press release which are not
purely historical are forward-looking statements and include any
statements regarding beliefs, plans, expectations or intentions
regarding the future. These forward-looking statements generally
can be identified by phrases such as EQ Labs, Inc. or its
management believes, expects, anticipates, foresees, forecasts,
estimates or other words or phrases of similar import. Such
forward-looking statements include, among other things, the
development, costs and results of new business opportunities.
Actual results could differ from those projected in any
forward-looking statements due to numerous factors. Such factors
include, among others, the inherent uncertainties associated with
new business opportunities and development stage companies. These
forward-looking statements are made as of the date of this news
release, and we assume no obligation to update the forward-looking
statements, or to update the reasons why actual results could
differ from those projected in the forward-looking statements.
Although we believe that any beliefs, plans, expectations and
intentions contained in this press release are reasonable, there
can be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all
of the information set forth herein and should also refer to the
risk factors disclosure outlined in our annual report, our
quarterly reports and other periodic reports filed from
time-to-time with the OTC Markets.
Contact Information:
EQ Labs, Inc
Maurice Owens, President and CEO
Phone: (702) 806-5943
Web: www.Drinkeq.com
Email: mo@drinkeq.com
Twitter: eqceo